Study offers insights for communicating about wildlife, zoonotic disease amid COVID-19

A new study from North Carolina State University found that certain types of messages could influence how people perceive information about the spread of diseases from wildlife to humans. The researchers say the findings, published in the journal Frontiers in Communication, could help scientists, policymakers and others more effectively communicate with diverse audiences about zoonotic…

Program seeks public engagement on how data can make food healthier and more sustainable

BROOKLYN, New York, Tuesday, June 1, 2021 – Worldwide, unsustainable farming practices are damaging both the global environment and the health and wellbeing of people everywhere. At the same time, climate change is making our food systems more fragile, while the global population continues to rapidly increase. Solving both of these challenges requires more sustainable…

Partners play pivotal role in pregnant women’s alcohol use and babies’ development

A new study by a team of University of Rochester psychologists and other researchers in the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) finds that partners of mothers-to-be can directly influence a pregnant woman’s likelihood of drinking alcohol and feeling depressed, which affects their babies’ development. The study, which appeared in Alcoholism: Clinical &…

At-home COVID-19 tests: How good are they?

As the country gets vaccinated and begins to re-open, testing remains a key element of safe interactions. Rapid testing for COVID-19 has become more common and accessible, including over-the-counter (OTC) tests approved by the U.S. Food and Drug Administration (FDA). Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, puts five…

Centivax and US Naval Medical Research Center announce strategic partnership

SAN FRANCISCO – June 2, 2021 — Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax’s SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic. Centi-B9 has been engineered to broadly neutralize the mutated emerging coronavirus variants, with…